bifidobacterium longum + lactoferrin Capsules 450 mg

This European pharmaceutical company boasts a rich history dating back to 1934, specializing in chemical and pharmaceutical production. They hold expertise in pediatric, bronchopneumological, rhinoiatric, and neuropsychiatric therapy areas. Their product portfolio likely includes prescription medications, over-the-counter drugs, and possibly medical devices, catering to various regions including the EU and North America. The company emphasizes innovation and quality, evidenced by their GMP certifications and potential product patents. Their pharmacovigilance responsibilities underscore their commitment to patient safety and regulatory compliance.